newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals Announces Issuance of New U.S. Patent for Zygel™

DEVON, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the U.S. Patent